http://www.asiahealthcareblog.com/2010/02/03/pfizers-china-strategy-shows-why-they-are-still-alive-in-the-big-pharma-consolidation-wars/ Exploring the intersection of investment and development, in Asia Thu, 09 Feb 2012 17:09:18 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://www.asiahealthcareblog.com/2010/02/03/pfizers-china-strategy-shows-why-they-are-still-alive-in-the-big-pharma-consolidation-wars/comment-page-1/#comment-6669 Damjan_D Fri, 05 Feb 2010 02:26:42 +0000 http://www.asiahealthcareblog.com/?p=1939#comment-6669 If we are talking about the period of time when drug companies were wining and dining American doctors, the no. If we are talking about the need to go door to door and really inform doctors about the merits of a product, then yes. If we are talking about the period of time when drug companies were wining and dining American doctors, the no. If we are talking about the need to go door to door and really inform doctors about the merits of a product, then yes.

]]> http://www.asiahealthcareblog.com/2010/02/03/pfizers-china-strategy-shows-why-they-are-still-alive-in-the-big-pharma-consolidation-wars/comment-page-1/#comment-6667 Ashley Thu, 04 Feb 2010 16:21:10 +0000 http://www.asiahealthcareblog.com/?p=1939#comment-6667 Do you agree with what WSJ says about the Pfizer China strategy being very similar to the strategy for the US a few years ago? I feel like China's doctor environment might no be quite there yet. Do you agree with what WSJ says about the Pfizer China strategy being very similar to the strategy for the US a few years ago? I feel like China's doctor environment might no be quite there yet.

]]>